anmelden
SMIM
3.209,03
PKT
+6,65
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.12 | Tecan (N) neutral | Sarasin Research | |
| 09.02.12 | Swatch (I) kaufen | Focus Money | |
| 08.02.12 | Swatch (I) buy | Société Générale Group S.A. (SG) | |
| 08.02.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | Swatch (I) buy | Sarasin Research | |
| 08.02.12 | Swatch (I) buy | Nomura | |
| 07.02.12 | Swatch (I) kaufen | Sarasin Research | |
| 07.02.12 | Julius Bär buy | Sarasin Research | |
| 06.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 03.02.12 | Roche outperform | Exane-BNP Paribas SA | |
| 03.02.12 | Roche overweight | Barclays Capital | |
| 02.02.12 | Roche neutral | Nomura | |
| 01.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 01.02.12 | Roche buy | Sarasin Research | |
| 31.01.12 | Roche overweight | J.P. Morgan Cazenove | |
| 30.01.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 30.01.12 | SGS SA neutral | Sarasin Research | |
| 26.01.12 | Roche overweight | Barclays Capital | |
| 25.01.12 | Roche outperform | Exane-BNP Paribas SA | |
| 25.01.12 | SGS SA hold | Société Générale Group S.A. (SG) | |
| 24.01.12 | Roche buy | Deutsche Bank AG | |
| 23.01.12 | Roche overweight | Barclays Capital | |
| 20.01.12 | ams-OSRAM kaufen | Erste Bank AG | |
| 19.01.12 | Roche overweight | Barclays Capital | |
| 18.01.12 | Clariant hold | Vontobel Research | |
| 18.01.12 | SGS SA buy | Vontobel Research | |
| 18.01.12 | Tecan (N) hold | Vontobel Research | |
| 17.01.12 | Galenica neutral | Sarasin Research | |
| 17.01.12 | SGS SA neutral | Sarasin Research | |
| 17.01.12 | SGS SA buy | Vontobel Research | |
| 17.01.12 | Barry Callebaut hold | Vontobel Research | |
| 17.01.12 | Galenica hold | Vontobel Research | |
| 16.01.12 | Lindt hold | Vontobel Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Sarasin Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Société Générale Group S.A. (SG) | |
| 13.01.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 12.01.12 | Swatch (I) overweight | HSBC | |
| 12.01.12 | Roche neutral | Nomura | |
| 11.01.12 | Clariant neutral | Citigroup Corp. |
